by Jeito Life | 20 Sep Mon | English
Oversubscribed Jeito I becomes the largest European fund dedicatedto the life sciences sector. Jeito Capital is dedicated to working with biotech entrepreneurs to provide financial and expert support in continuity to accelerate patients’ access to groundbreaking...
by Jeito Life | 28 Jul Wed | English
The appointment of Dr. Tordjman was granted by French Ministers, Agnès Pannier-Runacher and Franck Riester Paris, France, 28 July 2021 – Jeito Capital (“Jeito”), a rapidly emerging independent Private Equity firm dedicated to biotech and biopharma, today welcomes the...
by Jeito Life | 15 Jun Tue | English
Jeito Capital selects Alentis Therapeutics as its fifth investment since launching the fund Alentis is focused on the development of breakthrough treatments for fibrotic diseases and associated cancers Paris, France, 15 June 2021 – Jeito Capital (“Jeito”), a rapidly...
by Jeito Life | 27 May Thu | English
Jeito selects Pulmocide as its fourth investment since launching the fund Pulmocide is a clinical-stage biopharma company focused on the development of novel treatments for life-threatening respiratory diseases Paris, France, 27 May 2021 – Jeito Capital (“Jeito”), a...
by Jeito Life | 26 Jan Tue | English
The investment fund confirms the strength of its investment model in medical innovation, closing 2020 and celebrating its one-year anniversary with more than €250 million under management and first three investments. Paris, January 26th, 2021 – One year after...
Recent Comments